Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Nozomu Matsumoto Last modified date:2023.11.22

Associate Professor / Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University / Department of Clinical Medicine / Faculty of Medical Sciences


Papers
1. Nishimura, T. Hosoi, H. Sugiuchi, T. Matsumoto, N. Nishiyama, T. Kenichi, T. Sugimoto, S. Yazama, H. Sato, T. Komori, M., Factors Influencing the Purchase Rate of Cartilage Conduction Hearing Aids, J Am Acad Audiol, 10.1055/s-0041-1733965, 33, 1, 14-22, 2022.01, BACKGROUND: Innovated hearing aids (HAs), termed cartilage conduction hearing aids (CC-HAs), show good performance in patients with closed ears and continuous otorrhea. However, factors other than the ear condition that influence the purchase rate of CC-HAs remain unclear. PURPOSE: To identify the factors that influence the purchase rate of CC-HAs. RESEARCH DESIGN: A correlational study. STUDY SAMPLE: A total of 249 patients were enrolled. DATA COLLECTION AND ANALYSIS: The patients' demographics, clinical characteristics, outcomes, and CC-HA transducer types were compared. The data were analyzed for six groups classified based on the ear condition. RESULTS: In the unilateral closed-ear group, the purchase cases were significantly younger than the nonpurchase cases (p
2. Matsumoto, Nozomu Akagi-Tsuchihashi, Nana Noda, Teppei Komune, Noritaka Nakagawa, Takashi, Orientation of the Cochlea From a Surgeon’s Perspective, Otology & Neurotology Open, 10.1097/ono.0000000000000017, 2, 3, e017, 2022.09.
3. Uchida, Y. Mise, K. Suzuki, D. Fukunaga, Y. Hakuba, N. Oishi, N. Ogawa, T. Takahashi, M. Takumi, Y. Fujimoto, S. Maeda, Y. Nishizaki, K. Noda, T. Komune, N. Matsumoto, N. Nakagawa, T. Nishita, Y. Otsuka, R. Maegawa, A. Kimizuka, T. Miyata, A. Gonda, A. Ishikawa, K. Higashino, Y. Murakami, S.J Am Med Dir Assoc, A Multi-Institutional Study of Older Hearing Aids Beginners-A Prospective Single-Arm Observation on Executive Function and Social Interaction, J Am Med Dir Assoc, 10.1016/j.jamda.2021.02.035, 22, 6, 1168-1174, 2021.06, OBJECTIVES: To obtain new insights into research questions on how executive function and social interaction would be observed to change after the introduction of hearing aids (HAs) in older people with hearing impairment. DESIGN: Multi-institutional prospective single-arm observational study. SETTING AND PARTICIPANTS: Outpatients with complaints of hearing difficulty who visited HA clinics between October 18, 2017, and June 30, 2019, in 7 different university hospitals in Japan. METHODS: The inclusion criteria of the study named Hearing-Aid Introduction for Hearing-Impaired Seniors to Realize a Productive Aging Society-A Study Focusing on Executive Function and Social Activities Study (HA-ProA study) were age >/=60 years and no history of HA use. A series of multi-institution common evaluations including audiometric measurements, the digit symbol substitution test to assess executive functions, convoy model as an index of social relations, and hearing handicap inventory for the elderly (HHIE) were performed before (pre-HA) and after 6 months of the HA introduction (post-HA). RESULTS: Out of 127 enrollments, 94 participants completed a 6-month follow-up, with a mean age of 76.9 years. The digit symbol substitution test score improved significantly from 44.7 at baseline to 46.1 at 6 months (P = .0106). In the convoy model, the social network size indicated by the number of persons in each and whole circles were not significantly different between pre- and post-HA; however, the total count for kin was significantly increased (P = .0344). In the analyses of HHIE, the items regarding the family and relatives showed significant improvement. CONCLUSIONS AND IMPLICATIONS: HA use could benefit older individuals beginning to use HAs in executive function and social interaction, though the results should be interpreted cautiously given methodological limitations such as a single-arm short 6 months observation. Reduction in daily hearing impairment would have a favorable effect on relationships with the family..
4. Shimogawa, T. Mukae, N. Morioka, T. Sakata, A. Sakai, Y. Matsumoto, N. Mizoguchi, M., Corpus callosotomy for drug-resistant epilepsy in a pediatric patient with Waardenburg syndrome Type I, Surg Neurol Int, 10.25259/SNI_228_2021, 12, 217, 2021.05, BACKGROUND: Waardenburg syndrome (WS) is caused by autosomal dominant mutations. Since the coexistence of epilepsy and WS type I is rare, the detailed clinical features and treatment of epilepsy, including surgery, have not been fully reported for these patients. We report the first case of an individual with WS type I, who underwent corpus callosotomy (CC) for drug-resistant epilepsy and obtained good seizure outcomes. CASE DESCRIPTION: A boy was diagnosed as having WS type I and developmental delay based on characteristic symptoms and a family history of hearing loss. He underwent cochlear implantation at 18 months of age. At 4 years of age, he developed epileptic seizures with a semiology of drop attack. Electroencephalography (EEG) showed bilateral synchronous high-amplitude spikes and wave bursts, dominant in the right hemisphere. Based on the multimodality examinations, we considered that ictal discharges propagated from the entire right hemisphere to the left, resulting in synchronous discharge and a clinical drop attack; therefore, CC was indicated. At 9 years of age, he underwent a front 2/3(rd) CC. At 1 year, the patient became seizure free, and interictal EEG showed less frequent and lower amplitude spike and wave bursts than before. CONCLUSION: When patients with WS Type I and cognitive impairment show drug-resistant epilepsy, clinicians should consider a presurgical evaluation..
5. Nishimura, T. Hosoi, H. Sugiuchi, T. Matsumoto, N. Nishiyama, T. Kenichi, T. Sugimoto, S. Yazama, H. Sato, T. Komori, M., Cartilage Conduction Hearing Aid Fitting in Clinical Practice, J Am Acad Audiol, 10.1055/s-0041-1728758, 32, 6, 386-392, 2021.06, BACKGROUND: Cartilage conduction hearing aids (CCHAs) were newly devised and spread fast in Japan since their launch in 2017. However, little knowledge is available for this new device. PURPOSE: The aim of this study was to establish the knowledge of CCHAs and suggest their indication. RESEARCH DESIGN: Correlational study. STUDY SAMPLE: A total 256 patients were registered. DATA COLLECTION AND ANALYSIS: The fitting of CCHAs was surveyed in nine institutions. The outcomes were assessed by audiometric tests. The patients were classified into seven groups, depending on the ear conditions. The clinical characteristics, assessment results, and purchase rates were compared among the groups. The assessment results of CCHAs were also compared with those of previously used hearing aids. RESULTS: Most patients who used CCHAs were classified into the bilateral closed (aural atresia or severe stenosis) ear (n = 65) or unilateral closed ear (n = 124) groups. The patients in these groups achieved good benefits that resulted in a high purchase rate. The bilateral continuous otorrhea group also supported a high purchase rate, although the benefits of CCHAs were not always excellent. In contrast, the purchase rate was poor in the patients who could use air conduction hearing aids (ACHAs) without absolute problems. As for using a CCHA as a contralateral routing of signals hearing aid, the benefits depended on the patients. CONCLUSIONS: CCHAs are considered as a great option not only to the patients with closed ears but also to those who had difficulties in ACHAs usage..
6. Komune, N. Noda, T. Kogo, R. Miyazaki, M. Tsuchihashi, N. A. Hongo, T. Koike, K. Sato, K. Uchi, R. Wakasaki, T. Matsumoto, N. Yasumatsu, R. Nakagawa, T., Primary Advanced Squamous Cell Carcinoma of the Temporal Bone: A Single-Center Clinical Study, Laryngoscope, 10.1002/lary.28653, 131, 2, E583-E589, 2021.02, OBJECTIVES/HYPOTHESIS: The extreme rarity of temporal bone squamous cell carcinoma (TB-SCC) has delayed the accumulation of high-quality clinical evidence. For the purposes of retrospective meta-analysis in the future, a large dataset with information from various institutions would be ideal. Our objective here was to retrospectively review cases of TB-SCC encountered at a single tertiary referral center and explore survival outcomes and prognostic factors. STUDY DESIGN: Retrospective chart review. METHODS: The medical records of all TB-SCC cases were retrospectively reviewed. The resulting dataset contained 71 cases of primary cancer eligible for initial definitive (curative) treatment. RESULTS: T4 status was associated with lower disease-specific 5-year survival than T1 to T3 staging (T1: 100%, T2: 92%, T3: 86%, T4: 51%). Survival was significantly higher in operable than in inoperable cases, even when restricted to advanced (T3/T4) cancers. The tumor extension to the middle ear cavity was observed in 13/17 of T3 cases, but it was not associated with poor survival. In addition, among operable cases, negative surgical margins were associated with significantly higher survival than positive margins. CONCLUSIONS: Definitive treatments can offer disease-specific 5-year survival of over 85% in T1 to T3 cases of TB-SCC. The tumor extension to the middle ear cavity is not associated with poor survival. T4 status, inoperability, nodal invasion, and positive surgical margin are identified as a predictor of poor prognosis. Still, the matter of how to deal with unresectable tumors remains an outstanding issue in the treatment of TB-SCC. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E583-E589, 2021..
7. Komune, N. Higashino, Y. Ishikawa, K. Tabuki, T. Masuda, S. Koike, K. Hongo, T. Sato, K. Uchi, R. Miyazaki, M. Shimamoto, R. Tsuchihashi, N. A. Kogo, R. Noda, T. Matsumoto, N. Nakagawa, T., Management of Residual Hearing with Cartilage Conduction Hearing Aid after Lateral Temporal Bone Resection: Our Institutional Experience, Audiol Res, 10.3390/audiolres11020024, 11, 2, 263-274, 2021.06, BACKGROUND: There is no guideline for hearing compensation after temporal bone resection. This study aimed to retrospectively analyze surgical cases with reconstruction for hearing preservation after temporal bone malignancy resection and propose a new alternative to compensate for hearing loss. METHODS: We retrospectively reviewed the medical records of 30 patients who underwent lateral temporal bone surgery for temporal bone malignancy at our institution and examined their hearing abilities after surgery. RESULT: The hearing outcomes of patients with an external auditory meatus reconstruction varied widely. The mean postoperative air-bone gap at 0.5, 1, 2, and 4 kHz ranged from 22.5 dB to 71.25 dB. On the other hand, the average difference between the aided sound field thresholds with cartilage conduction hearing aid and bone conduction thresholds at 0.5, 1, 2, and 4 kHz ranged from -3.75 to 41.25. More closely located auricular cartilage and temporal bone resulted in smaller differences between the aided sound field and bone conduction thresholds. CONCLUSIONS: There is still room for improvement of surgical techniques for reconstruction of the auditory meatus to preserve hearing after temporal bone resection. The cartilage conduction hearing aid may provide non-invasive postoperative hearing compensation after lateral temporal bone resection..
8. Sato, K. Komune, N. Hongo, T. Koike, K. Niida, A. Uchi, R. Noda, T. Kogo, R. Matsumoto, N. Yamamoto, H. Masuda, M. Oda, Y. Mimori, K. Nakagawa, T., Genetic landscape of external auditory canal squamous cell carcinoma, Cancer Sci, 10.1111/cas.14515, 111, 8, 3010-3019, 2020.08, External auditory canal squamous cell carcinoma (EACSCC) is an extremely rare and aggressive malignancy. Due to its rarity, the molecular and genetic characteristics of EACSCC have not yet been elucidated. To reveal the genetic alterations of EACSCC, we performed whole exome sequencing (WES) on 11 primary tumors, 1 relapsed tumor and 10 noncancerous tissues from 10 patients with EACSCC, including 1 with a rare case of synchronous bilateral EACSCC of both ears. WES of the primary tumor samples showed that the most frequently mutated gene is TP53 (63.6%). In addition, recurrent mutations in CDKN2A, NOTCH1, NOTCH2, FAT1 and FAT3 were detected in multiple samples. The mutational signature analysis of primary tumors indicated that the mutational processes associated with the activation of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) deaminases are the most common in EACSCC, suggesting its similarity to SCC from other primary sites. Analysis of arm-level copy number alterations detected notable amplification of chromosomes 3q, 5p and 8q as well as deletion of 3p across multiple samples. Focal chromosomal aberrations included amplifications of 5p15.33 (ZDHHC11B) and 7p14.1 (TARP) as well as deletion of 9p21.3 (CDKN2A/B). The protein expression levels of ZDHHC11B and TARP in EACSCC tissues were validated by immunohistochemistry. Moreover, WES of the primary and relapsed tumors from a case of synchronous bilateral EACSCC showed the intrapatient genetic heterogeneity of EACSCC. In summary, this study provides the first evidence for genetic alterations of EACSCC. Our findings suggest that EACSCC mostly resembles other SCC..
9. Noda, T. Komune, N. Yasumatsu, R. Tsuchihashi, N. A. Tamae, A. Matsumoto, N. Sato, K. Uchi, R. Koike, K. Wakasaki, T. Tanaka, R. Nakagawa, T., Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma, Auris Nasus Larynx, 10.1016/j.anl.2020.03.011, 47, 5, 864-869, 2020.10, OBJECTIVE: The immune checkpoint inhibitor Nivolumab was approved for the treatment of platinum-refractory head and neck squamous cell carcinoma (SCC), expanding the treatment options for recurrent or advanced head and neck SCC. However, since temporal bone squamous cell carcinoma (TB-SCC) is very rare cancer, the effectiveness of Nivolumab remains unclear. We investigated the effects of Nivolumab for TB-SCC. METHOD: Chart information was collected for all patients who underwent the first administration of Nivolumab for recurrent or residual TB-SCC in our hospital between September 2017 and December 2019. Tumor staging followed the modified Pittsburgh classification. Changes in the tumor burden and survival outcome were examined. RESULTS: We examined 9 patients with recurrent or residual TB-SCC who started administration of Nivolumab. In these cases, recurrent or residual SCC was observed after chemotherapy and/or chemoradiotherapy including platinum. The duration of Nivolumab was 2-54 weeks (median 20.0 weeks). The evaluation of the therapeutic effect according to the RECIST method showed partial response in 1 case, stable disease in 2 cases, progressive disease in 4 cases, and size unevaluated in 2 case. Although the number of cases was small, comparing with 5 cases without Nivolumab, these cases showed longer overall survival (1-year OS 33.3% vs 20.0%). CONCLUSION: We used Nivolumab as palliative chemotherapy in 9 patients with recurrent/residual TB-SCC, and we were able to obtain a certain therapeutic effect on TB-SCC as well as other head and neck SCC..
10. Matsumoto, N. Yamashita, M. Cho, B. Komune, N. Hashizume, M., Asymmetrical surface scanning registration for image-guided otologic surgery: A phantom study, Auris Nasus Larynx, 10.1016/j.anl.2020.01.007, 47, 4, 574-579, 2020.08, OBJECTIVE: To develop a registration procedure to achieve a higher degree of registration accuracy in image-guided otological surgery, paying particular attention to the registration centroid. METHODS: A head phantom was used to measure the target registration error (TRE) at measurement points at various depth from the surface of the head. The surface-matching registration was performed using a commercially available surgical navigation system. We registered the phantom using only one ear of either side (right 100% - left 0%, or right 0% - left 100%) or using both ears with variable ratios (right 75% - left 25%, right 50% - left 50%, or right 25% - left 75%). RESULTS: The overall TRE was the smallest when registration was performed equally on both sides. However, the TRE at 20-50 mm from the surface was the smallest when the fiducial points for the registration were collected asymmetrically at a ratio of 75:25 and weighed heavier on the operating side, and this difference was statistically significant. CONCLUSION: The accuracy of image-guided surgery can be improved by carefully planning the registration procedure without changing the procedure itself. Accurate image-guided surgery at the middle and inner ear was achieved using 75% of the point cloud for the operating side and 25% of that for the opposite side for the registration..
11. Komune, N. Masuda, S. Yasumatsu, R. Hongo, T. Jiromaru, R. Matsuo, S. Akiyama, O. Tsuchihashi, N. Matsumoto, N. Yamamoto, H. Nakagawa, T., Malignant perivascular epithelioid cell tumor mimicking jugular foramen schwannoma: A case report and literature review, Heliyon, 10.1016/j.heliyon.2020.e03200, 6, 1, E03200, 2020.01.
12. Fukushima, S. Komune, N. Kamizono, K. Matsumoto, N. Takaiwa, K. Nakagawa, T. Kadota, H., Use of negative pressure wound therapy to treat a cochlear implant infection around the auricle: a case report, J Wound Care, 10.12968/jowc.2020.29.10.568, 29, 10, 568-571, 2020.10, lthough negative pressure wound therapy (NPWT) is widely used, its application to the head and neck region remains challenging due to anatomical complexities. This report presents the case of a female patient presenting with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes, uncontrolled diabetes and severe bilateral sensorineural hearing loss. The patient had undergone cochlear implant surgery and five months later the wound was infected with methicillin-resistant Staphylococcus aureus (MRSA). NPWT was started shortly after removing the internal receiver and was stopped 11 days later. NPWT helped in controlling infection and led to a successful wound closure. In this case, NPWT was effective in treating infectious wounds around the auricle after cochlear implant surgery. Declaration of interest: The authors have no financial support for this article and no conflict of interest directly relevant to the content of this article..
13. Yamashita, K. Hiwatashi, A. Togao, O. Kikuchi, K. Shimomiya, Y. Kamei, R. Momosaka, D. Matsumoto, N. Kobayashi, K. Takemura, A. Kwee, T. C. Takahara, T. Honda, H., Improved Visualization of Middle Ear Cholesteatoma with Computed Diffusion-weighted Imaging, Magn Reson Med Sci, 10.2463/mrms.tn.2018-0068, 18, 3, 233-237, 2019.07, Computed DWI (cDWI) is a mathematical technique that calculates arbitrary higher b value images from at least two different lower b values. In addition, the removal of high intensity noise with image processing on cDWI could improve cholesteatoma-background contrast-to-noise ratio (CNR). In the present study, noise reduction was performed by the cut-off values of apparent diffusion coefficient (ADC) less than 0 and 0.4 x 10(-3) s/mm(2). The cholesteatoma to non-cholesteatoma CNR was increased using a noise reduction algorithm for clinical setting..
14. Yamashita, K. Hiwatashi, A. Togao, O. Kikuchi, K. Matsumoto, N. Momosaka, D. Nakatake, H. Sakai, Y. Honda, H., Ultrahigh-resolution CT scan of the temporal bone, Eur Arch Otorhinolaryngol, 10.1007/s00405-018-5101-6, 275, 11, 2797-2803, 2018.11, OBJECTIVE: Ultrahigh-resolution CT (U-HRCT) provides better spatial resolution than conventional multi-detector row CT (ConvCT) and could be expected to identify microstructures with its 0.25-mm collimation, 1792 channels and 160 detector rows, 0.4 x 0.5 mm focus size, and a 1024 matrix. The aim of the study was to evaluate key anatomic structures in temporal bone using U-HRCT comparing it to ConvCT. MATERIALS AND METHODS: A total of 30 patients (14 males and 16 females; age range, 8-82 years; median 49 years) underwent both U-HRCT and ConvCT. All CT images were obtained with 0.5 mm section thickness and a 512 x 512 matrix, and field of view of 80 mm. Transverse scans were acquired in a plane parallel to the orbitomeatal plane in the helical mode with 120 kV. Images of the 30 temporal bones of unaffected side were reviewed by two independent neuroradiologists who rated the visibility of key anatomic structures for both U-HRCT and ConvCT. The ratings between U-HRCT and ConvCT were compared using Wilcoxon matched-pairs signed rank test. The interobserver agreement on the rating of stapedius tendon was evaluated using weighted kappa statistics. RESULTS: Excellent interobserver agreement was shown for U-HRCT (kappa = 0.920), whereas good agreement was obtained for ConvCT (kappa = 0.733). According to both observers, stapedius tendon was more clearly visualized using U-HRCT than ConvCT (p
15. Tamae, A. Ishizu, K. Yoshida, T. Kubo, K. Matsumoto, N. Yasui, T. Masutani, K. Tsuruya, K. Nakagawa, T., Evaluation of the Effects of Chronic Kidney Disease and Hemodialysis on the Inner Ear Using Multifrequency Tympanometry, J Int Adv Otol, 10.5152/iao.2018.4736, 14, 3, 447-450, 2018.11, OBJECTIVES: To evaluate the effects of chronic kidney disease (CKD) and hemodialysis (HD) on the inner ear using the G width (the width between the bimodal peaks of the conductance (G) tympanogram at 2,000 Hz), which reflects the inner ear pressure and/or the existence of endolymphatic hydrops. MATERIALS AND METHODS: We selected five patients (10 ears) from the patients with CKD who were hospitalized for creation of arteriovenous fistula prior to initiation of HD (non-HD group), and we selected seven patients (14 ears) from the patients with CKD who were undergoing HD (the HD group). As a control group, we selected 80 healthy individuals (160 ears); these were mainly the medical staff of the hospital. We measured the G width of the control group and that of patients with CKD using multifrequency tympanometry. RESULTS: The mean G widths of the HD (measured just before an HD session), non-HD, and control groups were 210.7, 128.4, and 97.0 daPa, respectively. The G width of the HD group was significantly greater than that of the control and non-HD groups (p
16. Matsumoto, N. Suzuki, N. Iwasaki, S. Ishikawa, K. Tsukiji, H. Higashino, Y. Tabuki, T. Nakagawa, T., Language-specific strategy for programming hearing aids - A double-blind randomized controlled crossover study, Auris Nasus Larynx, 10.1016/j.anl.2017.11.007, 45, 4, 686-692, 2018.08, OBJECTIVE: Voice-aligned compression (VAC) is a method used in Oticon's hearing aids to provide more comfortable hearing without sacrificing speech discrimination. The complex, non-linear compression curve for the VAC strategy is designed based on the frequency profile of certain spoken Western languages. We hypothesized that hearing aids could be further customized for Japanese-speaking users by modifying the compression curve using the frequency profile of spoken Japanese. METHODS: A double-blind randomized controlled crossover study was performed to determine whether or not Oticon's modified amplification strategy (VAC-J) provides subjectively preferable hearing aids for Japanese-speaking hearing aid users compared to the same company's original amplification strategy (VAC). The participants were randomized to two groups. The VAC-first group received a pair of hearing aids programmed using the VAC strategy and wore them for three weeks, and then received a pair of hearing aids programmed using VAC-J strategy and wore them for three weeks. The VAC-J-first group underwent the same study, but they received hearing aids in the reverse sequence. A Speech, Spatial and Qualities (SSQ) questionnaire was administered before beginning to use the hearing aids, at the end of using the first pair of hearing aids, and at the end of using the second pair of hearing aids. RESULTS: Twenty-five participants that met the inclusion/exclusion criteria from January 1 to October 31, 2016, were randomized to two groups. Twenty-two participants completed the study. There were no statistically significant differences in the increment of SSQ scores between the participants when using the VAC- or the VAC-J-programmed hearing aids. However, participants preferred the VAC-J strategy to the VAC strategy at the end of the study, and this difference was statistically significant. CONCLUSION: Japanese-speaking hearing aid users preferred using hearing aids that were fitted with the VAC-J strategy. Our results show that the VAC strategy can be adjusted to the frequency profile of different languages and that participants expressed their subjective preference more clearly than was reflected in the SSQ scores. A similar language-specific strategy may improve user's satisfaction while using hearing devices, and this concept may be extended to implantable hearing devices. CLINICAL RESEARCH REGISTRATION NUMBER: R000023191..
17. Ishizu, K. Tamae, A. Kubo, K. Yoshida, T. Matsumoto, N. Yasui, T. Nakagawa, T., Diagnosis and following up of Meniere's disease using multifrequency tympanometry-Cutoff values and temporal changes in measurements, Auris Nasus Larynx, 10.1016/j.anl.2017.05.008, 45, 1, 81-87, 2018.02, BJECTIVE: This study aimed to verify cutoff values for G width (the width of bimodal peaks for the waveform obtained when measuring conductance at 2000Hz) in Japanese individuals diagnosed with Meniere's disease (MD) using multifrequency tympanometry (MFT) and to determine the relationship between the G width and ability to hear low-pitched sounds using measurements over time. METHODS: The study included 51 patients with clinically diagnosed MD, who had not undergone endolymphatic sac surgery, but had no other known ear disease (57 ears in patients aged 22-80 years were affected, and 45 ears in patients aged 18-83 years were unaffected; mean age: 53.3+/-16.9 years). We also enlisted 80 healthy controls with no prior history of ear disease (160 ears, aged 22-76 years, mean age: 40.8+/-15.7 years). MFT was used to measure the bimodal peak width of the waveform obtained when measuring conductance at resonance frequency of 2000Hz. For patients who had G width measured several times over multiple outpatient visits, we used initial test data to analyze cutoff values. In nine cases with four or more measurements over time, we evaluated a possible correlation between G width and the sum of the hearing threshold for three low-pitched frequencies (125Hz, 250Hz, and 500Hz). We used Student's t-test to determine significance. RESULTS: The both ears in the MD patients had a G width wider than the distribution in the control group. There was a significant difference between G width in the control group and in affected ears with MD (p=0.00026) and there was also a significant difference between G width in the control group and in unaffected ears of MD patients (p=0.0056). The cutoff value set with a specificity of 95% was 200daPa, with a sensitivity of 35.1% and specificity of 95.6%. The cutoff value set with a sensitivity of 50% was 140daPa, with sensitivity of 50.9% and specificity of 78.8%. There was no significant difference between resonance frequency of ears in the control group and ears with MD (p=0.41). In nine cases with four or more measurements over time, a case showed a statistically significant positive correlation between the G width and hearing ability threshold for low-pitched sounds (125Hz, 250Hz, and 500Hz) (p=0.03), while an another case showed a tendency toward a positive correlation, which was not statistically significant (p=0.08). Further, there were cases that did not show significant differences in the present study, but might have shown a negative correlation if the number of measurements had been increased. CONCLUSION: Measurement of G width using MFT may have accuracy as the traditional endolymphatic hydrops test. MFT is non-invasive, causes little discomfort for patients, requires little time to perform, and can be performed by paramedics. MFT was shown to be useful in screening for MD and it is effective in diagnosing MD to measure the change over time of G width using MFT..
18. Matsumoto, N. Yamashita, M. Cho, B. Hashizume, M., Preoperative simulation unveiled undetected surgical difficulties in a case of cochlear implantation, BMJ Case Rep, 10.1136/bcr-2017-222657, 2017, 2017.12.
19. Komune, N. Matsushima, K. Matsuo, S. Safavi-Abbasi, S. Matsumoto, N. Rhoton, A. L., Jr., The accuracy of an electromagnetic navigation system in lateral skull base approaches, Laryngoscope, 10.1002/lary.25998, 127, 2, 450-459, 2017.02.
20. Yamashita, M. Matsumoto, N. Cho, B. Komune, N. Onogi, S. Lee, J. Bano, J. Akahoshi, T. Hashizume, M., Registration using 3D-printed rigid templates outperforms manually scanned surface matching in image-guided temporal bone surgery, Int J Comput Assist Radiol Surg, 10.1007/s11548-016-1441-0, 11, 11, 2119-2127, 2016.11.
21. Matsumoto, N., Role of computers and robots in future otological surgery, Hanyang Med Rev, 36, 230-236, 2016.10.
22. Nozomu Matsumoto, Lim, Hoon, Cho, Byunghyun, Hong, Jaesung, Yamashita, Makoto, Hashizume, Makoto, Yi, Byung-Ju, Semi-manual mastoidectomy assisted by human-robot collaborative control - A temporal bone replica study, AURIS NASUS LARYNX, 10.1016/j.anl.2015.08.008, 43, 2, 161-165, 2016.04.
23. Yasui, T., Ohashi, M., Nozomu Matsumoto, Komune, S., Analysis of the passive damped oscillation of the guinea pig stapes, JOURNAL OF LARYNGOLOGY AND OTOLOGY, 10.1017/S0022215114002308, 129, S2-S5, 2015.03.
24. Nozomu Matsumoto, High-resolution three-dimensional diffusion-weighted MRI/CT image data fusion for cholesteatoma surgical planning: a feasibility study, EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 10.1007/s00405-014-3467-7, 272, 12, 3821-3824, 2015.12.
25. Nozomu Matsumoto, Takumi, Y., Cho, B., Mori, K., Usami, S., Yamashita, M., Hashizume, M., Komune, S., Template-guided implantation of the Bonebridge: clinical experience., 272: 3669-3675, 2015.01.
26. Kubota, M., Kubo, K., Yasui, T., Nozomu Matsumoto, Komune, S., Development of conductive hearing loss due to posterior semicircular canal dehiscence, Auris Nasus Larynx, 42, 245-248, 2015.01.
27. Kamizono, K., Yoshida, S., Cho, B., Nozomu Matsumoto, Fukushima, J., Jinnouchi, M., Ouchida, R., Sawatsubashi, M., Hashizume, M., Komune, S., Safe and rapid contouring of fibro-osseous lesions in the orbital area using navigation with minimally invasive cranial bone registration., The Journal of laryngology and otology, 129 Suppl 2, S62-S68, 2015.01.
28. Ishizu, K., Yasui, T., Ohashi, M., Nozomu Matsumoto, Komune, S., High-speed video analysis of acoustically oscillated guinea pig stapes., 129 suppl 2, S33-S37, 2015.01.
29. Takumi, Y., Nozomu Matsumoto, Cho, B., Ono, H., Mori, K., Tsukada, K., Ichinose, A., Yoshimura, H., Iwasaki, S., Komune, S., Usami, S., A clinical experience of 'STAMP' plate-guided Bonebridge implantation., Acta oto-laryngologica 2014; 134: 1042-1046. , 134, 1042-1046, 2014.01.
30. CHO BYUNGHYUN, Nozomu Matsumoto, 森 恩, Shizuo Komune, Makoto Hashizume, Image-guided placement of the Bonebridge without surgical navigation equipment, Int J Comput Assist Radiol Surg, 2014.01.
31. CHO BYUNGHYUN, Nozomu Matsumoto, Makoto Hashizume, Navigation for cochlear implantation., Conf Proc IEEE Eng Med Biol Soc., 10.1109/EMBC.2013.6610851, 2014.01.
32. Oka M, Cho B, Nozomu Matsumoto, Hong J, Jinnouchi M, Ouchida R, Komune S, Hashizume M, A preregistered STAMP method for image-guided temporal bone surgery., Int J Comput Assist Radiol Surg, 2013.01.
33. Yamashita K, Yoshiura T, Hiwatashi A, Obara M, Togao O, Nozomu Matsumoto, Kikuchi K, Honda H, High-resolution three-dimensional diffusion-weighted imaging of middle ear cholesteatoma at 3.0T MRI: Usefulness of 3D turbo field-echo with diffusion-sensitized driven-equilibrium preparation (TFE-DSDE) compared to single-shot echo-planar imaging., Eur J Radiol, 2013.01.
34. Byunghyun Cho, Masamichi Oka, Nozomu Matsumoto, Riichi Ouchida, Jaesung Hong, Makoto Hashizume, Warning navigation system using real-time safe region monitoring for otologic surgery., Int J Comput Assist Radiol Surg. , 8, 3, 395-405, 2013.01.
35. Nozomu Matsumoto, Masamichi Oka, Byunghyun Cho, Jaesung Hong, Misaki Jinnouchi, Riichi Ouchida, Makoto Hashizume, and Shizuo Komune, Cochlear implantation assisted by noninvasive image guidance, Otology & Neurotology, 印刷中, 2012.08.
36. Kiyohara H, Sawatsubashi M, Matsumoto N, Komune S., Benign osteoblastoma of the ethmoid sinus, Auris Nasus Larynx, Auris Nasus Larynx. 2012 Aug 3., 2012.08.
37. Matsumoto N, Kitani R, Kalinec F., Linking LIMK1 deficiency to hyperacusis and progressive hearing loss in individuals with Williams syndrome, Commun Integr Biol, 4(2):208-10., 2011.03.
38. Matsumoto N, Kitani R, Maricle A, Mueller M, Kalinec F., Pivotal role of actin depolymerization in the regulation of cochlear outer hair cell motility., Biophys J. , 99(7):2067-76., 2010.10.
39. Matsumoto, N; Jaesung Hong, J; Hashizume, M; Komune, S, A minimally invasive registration method using surface template-assisted marker positioning (STAMP) for image-guided otologic surgery, Otolaryngology – Head and Neck Surgery, vol. 140, pp. 96-102, 2009.01.
40. Hong, J.; Matsumoto, N.; Ouchida, R.; Komune, S.; Hashizume, M., Medical Navigation System for Otologic Surgery Based on Hybrid Registration and Virtual Intraoperative Computed Tomography, IEEE Transactions on Biomedical Engineering, vol. 56: pp. 426-32, 2009.02.
41. Matsumoto N, Noda E, Nabekura J., Run down of GABAergic depolarization during metabolic inhibition of rat hippocampal CA1 neurons., Life Sci. 2006 , 79(11):1021-6., 2006.08.
42. Matsumoto N, Kalinec F., Extraction of prestin-dependent and prestin-independent components from complex motile responses in guinea pig outer hair cells., Biophys J., 89(6):4343-51., 2005.12.
43. Matsumoto N, Kalinec F., Prestin-dependent and prestin-independent motility of guinea pig outer hair cells., Hear Res., 208(1-2):1-13., 2005.10.
44. Matsumoto N, Sorimachi M, Akaike N., Excitatory effects of ATP on rat dorsomedial hypothalamic neurons., Brain Res., 10.1016/j.brainres.2004.03.001, 1009, 1-2, 234-237, 1009(1-2):234-7., 2004.05.
45. Matsumoto N, Komiyama S, Akaike N., Pre- and postsynaptic ATP-sensitive potassium channels during metabolic inhibition of rat hippocampal CA1 neurons., J Physiol, 10.1113/jphysiol.2002.018267, 541, 2, 511-520, 541(Pt 2):511-20., 2002.06.